pyogenes, one of the major pathogens involved in bacterial pharyngitis (Wescombe et al., 2009). There have been no reports of negative effects associated with the use of S. salivarius as an oral probiotic over the last few years.

The use of safe commensal organisms able to interfere with pathogens as a sort of ‘bacteria-therapy’ may offer a valid alternative to antibiotics in the prevention or treatment of bacterial infections. This Opaganib molecular weight hypothesis led us to screen commensal bacteria species from healthy children to use them as possible pathogen-inhibitor agents. We collected 13 α-haemolytic streptococci from nasal and pharyngeal swabs and only one strain of Streptococcus salivarius 24SMB was selected as a potential oral probiotic for its characteristics of the following: potential safety for the host, potent capacity of adhesion to HEp-2 cells, and excellent inhibitory activity against Streptococcus pneumoniae. Thirty-one swabs from healthy children taken during routine check-ups were analyzed for α-haemolytic strains. The children did not have URTIs. The 31 nasal and/or pharyngeal swabs were plated directly onto Columbia Agar Base (Oxoid, Basingstoke, UK), plus 5% horse blood to determine a total microflora population and Mitis Salivarius agar (Difco Laboratories), a selective medium for streptococci, used for differentiation of the viridans strains. Cultures

were incubated overnight at 37 °C in 5% CO2 in air atmosphere. A total CH5424802 of 81 α-haemolytic PJ34 HCl streptococci were isolated and identified by API Strep and sequencing of 16S rRNA gene and the sodA gene encoding for superoxide dismutase and used for correct speciation (Santagati et al., 2009; Teles et al., 2011). All strains were frozen at −70 °C in Brain heart infusion broth (Oxoid) with 20% glycerol. Tests for susceptibility to erythromycin, tetracycline, amoxicillin and penicillin were performed by the disc-diffusion test as recommended by EUCAST (http://www.eucast.org/clinical_breakpoints;

European Committee on Antimicrobial Susceptibility Testing, 2011). Each morphologically distinct colony grown in Mitis Salivarius agar was tested for BLIS production using a deferred antagonism test on Columbia Agar Base (Oxoid) supplemented with 5% horse blood and 0.1% CaCO3 (Tagg & Bannister, 1979). The test strain was inoculated diametrically across the test agar plate as a 1-cm wide streak. The visible growth of the test strain was removed using a glass slide, and the surface of the plate was sterilized by exposure to chloroform vapors for 30 min. The agar surface was then aired to remove residual chloroform for 15 min. Then, Todd Hewitt broth cultures of the indicator strains, grown for 18 h at 37 °C, were streaked across the growth line of the original producer strain for BLIS production. The plates were incubated for 18 h at 37 °C and examined for interference zones with the indicator.